Avastin-Injections in Age Related Macular Degeneration: Prospective Study for Optimal Frequency and Follow-up Determination.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2014
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 16 Sep 2014 New trial record
- 01 Mar 2011 Recruitment completed according to results published in the Acta Ophthalmologica.